The UK blood transfusion service: over a (patent) barrel?

被引：31

作者：

Simmonds, P ^{[1
]}

Kurtz, J

Tedder, RS

机构：

[1] Univ Edinburgh, Lab Clin & Mol Biol, Edinburgh EH9 1QH, Midlothian, Scotland

[2] Windeyer Inst Med Sci, Dept Virol, London, England

[3] Birmingham Ctr, Natl Blood Serv, Birmingham, W Midlands, England

来源：

LANCET | 2002年 / 359卷 / 9319期

关键词：

D O I：

10.1016/S0140-6736(02)08663-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1713 / 1714

页数：2

共 7 条

[1] Economics notes - Using cost effectiveness information [J].

Briggs, A ;

Gray, A .

BRITISH MEDICAL JOURNAL, 2000, 320 (7229) :246-246

[2]

Courouce AM, 1996, NEW ENGL J MED, V335, P1609

[3] Treatment of acute hepatitis C with interferon alfa-2b [J].

Jaeckel, E ;

Cornberg, M ;

Wedemeyer, H ;

Santantonio, T ;

Mayer, J ;

Zankel, M ;

Pastore, G ;

Dietrich, M ;

Trautwein, C ;

Manns, MP .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (20) :1452-1457

[4] The risk of transfusion-transmitted viral infections [J].

Schreiber, GB ;

Busch, MP ;

Kleinman, SH ;

Korelitz, JJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1685-1690

[5]

*SER HAZ TRANSF ST, 2000, SER HAZ TRANSF ANN R

[6] LONG-TERM SURVIVAL AFTER BLOOD-TRANSFUSION [J].

VAMVAKAS, EC ;

TASWELL, HF .

TRANSFUSION, 1994, 34 (06) :471-477

[7] Cost effectiveness of interferon α2b combined with ribavirin for the treatment of chronic hepatitis C [J].

Younossi, ZM ;

Singer, ME ;

McHutchison, JG ;

Shermock, KM .

HEPATOLOGY, 1999, 30 (05) :1318-1324

← 1 →